Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
1.960
-0.170 (-7.98%)
At close: Apr 1, 2025, 4:00 PM
2.070
+0.110 (5.61%)
After-hours: Apr 1, 2025, 7:55 PM EST

Perspective Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Jun '22 Jun '21 2020 - 2016
Market Capitalization
1452161133544113
Upgrade
Market Cap Growth
91.16%91.16%221.19%-19.99%-61.12%200.36%
Upgrade
Enterprise Value
-78-4898-19-1449
Upgrade
Last Close Price
1.963.194.022.473.097.98
Upgrade
PS Ratio
86.85148.2878.656.49-11.23
Upgrade
PB Ratio
0.480.741.500.640.721.68
Upgrade
P/TBV Ratio
0.900.90147.820.640.721.68
Upgrade
EV/Sales Ratio
-68.42--4.86
Upgrade
Debt / Equity Ratio
0.010.010.03-0.010.01
Upgrade
Asset Turnover
0.010.010.02--0.25
Upgrade
Inventory Turnover
-----6.07
Upgrade
Quick Ratio
12.5312.530.6714.4725.3836.58
Upgrade
Current Ratio
12.6812.681.0817.0726.1837.37
Upgrade
Return on Equity (ROE)
-42.82%-42.82%-57.70%--9.79%-9.26%
Upgrade
Return on Assets (ROA)
-19.02%-19.02%-32.81%--5.95%-5.43%
Upgrade
Return on Capital (ROIC)
-22.42%-22.42%-38.66%--6.17%-5.73%
Upgrade
Earnings Yield
-54.62%-36.77%-41.23%-30.64%-16.57%-3.00%
Upgrade
FCF Yield
-50.09%-33.72%-33.68%-30.42%-18.17%-2.85%
Upgrade
Buyback Yield / Dilution
-140.72%-140.72%-88.38%-0.06%-36.73%-53.61%
Upgrade
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q